Earnings Summary

Regeneron Pharmaceuticals, Inc.’s revenue jumped 12.32% since last year same period to $3547.1Mn in the Q2 2024. On a quarterly growth basis, Regeneron Pharmaceuticals, Inc. has generated 12.79% jump in its revenue since last 3-months.

Regeneron Pharmaceuticals, Inc.’s net profit jumped 47.9% since last year same period to $1432.3Mn in the Q2 2024. On a quarterly growth basis, Regeneron Pharmaceuticals, Inc. has generated 98.38% jump in its net profits since last 3-months.

Regeneron Pharmaceuticals, Inc.’s net profit margin jumped 31.68% since last year same period to 40.38% in the Q2 2024. On a quarterly growth basis, Regeneron Pharmaceuticals, Inc. has generated 75.89% jump in its net profit margins since last 3-months.

Regeneron Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current quarter stand at 11.81 - a 11.31% jump from last quarter’s estimates.

Regeneron Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current year stand at 11.81.

Regeneron Pharmaceuticals, Inc.’s earning per share (EPS) jumped 12.89% since last year same period to 11.56 in the Q2 2024. This indicates that the Regeneron Pharmaceuticals, Inc. has generated 12.89% annual rate of jump in its earning per share (EPS) in the last 4 quarters.